Regenera Pharma

Regenera Pharma is a leading pharmaceutical manufacturing company dedicated to transforming the treatment of central nervous system disorders. With a focus on innovation and patient well-being, Regenera Pharma is committed to developing therapies that restore neural function and improve the lives of individuals affected by neurological and neurodegenerative conditions. Their primary address is located at 18 Einstein Street, Ness-Ziona, N/A 7403622, IL.

Regenera Pharma's lead drug candidate, RPh201, holds immense potential for a wide range of neurological disorders. The company is currently advancing clinical trials for NAION (Nonarteritic Anterior Ischemic Optic Neuropathy) and Alzheimer's disease, demonstrating its commitment to addressing critical unmet medical needs. In addition, Regenera Pharma is collaborating with Henry Ford Health System to explore the therapeutic effects of RPh201 on stroke recovery, further expanding its research and development efforts.

Regenera Pharma's unwavering dedication to scientific excellence and patient-centric innovation positions it as a key player in the pharmaceutical industry. Information about Regenera Pharma's comprehensive product portfolio and ongoing research initiatives will be completed soon with the support of the company’s management. We invite the manager of Regenera Pharma to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work and commercial offerings.